Logo image of COVH.PA

COVIVIO HOTELS SACA (COVH.PA) Stock Fundamental Analysis

EPA:COVH - Euronext Paris - Matif - FR0000060303 - REIT - Currency: EUR

23.9  +0.1 (+0.42%)

Fundamental Rating

4

Overall COVH gets a fundamental rating of 4 out of 10. We evaluated COVH against 42 industry peers in the Diversified REITs industry. COVH has only an average score on both its financial health and profitability. COVH is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

In the past year COVH was profitable.
COVH had a positive operating cash flow in the past year.
In multiple years COVH reported negative net income over the last 5 years.
In the past 5 years COVH always reported a positive cash flow from operatings.
COVH.PA Yearly Net Income VS EBIT VS OCF VS FCFCOVH.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M 400M

1.2 Ratios

With a decent Return On Assets value of 3.14%, COVH is doing good in the industry, outperforming 66.67% of the companies in the same industry.
With a decent Return On Equity value of 6.54%, COVH is doing good in the industry, outperforming 73.81% of the companies in the same industry.
The Return On Invested Capital of COVH (3.98%) is better than 69.05% of its industry peers.
The Average Return On Invested Capital over the past 3 years for COVH is in line with the industry average of 3.60%.
The 3 year average ROIC (3.85%) for COVH is below the current ROIC(3.98%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 3.14%
ROE 6.54%
ROIC 3.98%
ROA(3y)3.26%
ROA(5y)1.11%
ROE(3y)6.53%
ROE(5y)1.93%
ROIC(3y)3.85%
ROIC(5y)2.91%
COVH.PA Yearly ROA, ROE, ROICCOVH.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 -5 10 -10

1.3 Margins

COVH has a better Profit Margin (80.73%) than 85.71% of its industry peers.
COVH's Profit Margin has declined in the last couple of years.
Looking at the Operating Margin, with a value of 103.45%, COVH belongs to the top of the industry, outperforming 97.62% of the companies in the same industry.
In the last couple of years the Operating Margin of COVH has remained more or less at the same level.
The Gross Margin of COVH (13.66%) is worse than 78.57% of its industry peers.
In the last couple of years the Gross Margin of COVH has declined.
Industry RankSector Rank
OM 103.45%
PM (TTM) 80.73%
GM 13.66%
OM growth 3Y10.91%
OM growth 5Y0%
PM growth 3Y43.44%
PM growth 5Y-10.66%
GM growth 3Y-31.67%
GM growth 5Y-15.65%
COVH.PA Yearly Profit, Operating, Gross MarginsCOVH.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100 -100 -200

4

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), COVH is destroying value.
Compared to 1 year ago, COVH has about the same amount of shares outstanding.
COVH has more shares outstanding than it did 5 years ago.
COVH has a worse debt/assets ratio than last year.
COVH.PA Yearly Shares OutstandingCOVH.PA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M
COVH.PA Yearly Total Debt VS Total AssetsCOVH.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

2.2 Solvency

COVH has an Altman-Z score of 1.05. This is a bad value and indicates that COVH is not financially healthy and even has some risk of bankruptcy.
COVH has a better Altman-Z score (1.05) than 64.29% of its industry peers.
COVH has a debt to FCF ratio of 14.45. This is a negative value and a sign of low solvency as COVH would need 14.45 years to pay back of all of its debts.
With a Debt to FCF ratio value of 14.45, COVH perfoms like the industry average, outperforming 42.86% of the companies in the same industry.
COVH has a Debt/Equity ratio of 0.74. This is a neutral value indicating COVH is somewhat dependend on debt financing.
The Debt to Equity ratio of COVH (0.74) is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.74
Debt/FCF 14.45
Altman-Z 1.05
ROIC/WACC0.75
WACC5.28%
COVH.PA Yearly LT Debt VS Equity VS FCFCOVH.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B 2B 3B

2.3 Liquidity

A Current Ratio of 1.06 indicates that COVH should not have too much problems paying its short term obligations.
Looking at the Current ratio, with a value of 1.06, COVH is in the better half of the industry, outperforming 76.19% of the companies in the same industry.
A Quick Ratio of 1.06 indicates that COVH should not have too much problems paying its short term obligations.
COVH has a Quick ratio of 1.06. This is amongst the best in the industry. COVH outperforms 80.95% of its industry peers.
Industry RankSector Rank
Current Ratio 1.06
Quick Ratio 1.06
COVH.PA Yearly Current Assets VS Current LiabilitesCOVH.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

4

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 245.77% over the past year.
The earnings per share for COVH have been decreasing by -12.16% on average. This is quite bad
The Revenue has decreased by -4.97% in the past year.
Measured over the past years, COVH shows a small growth in Revenue. The Revenue has been growing by 2.29% on average per year.
EPS 1Y (TTM)245.77%
EPS 3Y62.03%
EPS 5Y-12.16%
EPS Q2Q%-13.75%
Revenue 1Y (TTM)-4.97%
Revenue growth 3Y14.81%
Revenue growth 5Y2.29%
Sales Q2Q%-12.37%

3.2 Future

The Earnings Per Share is expected to grow by 0.90% on average over the next years.
Based on estimates for the next years, COVH will show a small growth in Revenue. The Revenue will grow by 0.55% on average per year.
EPS Next Y3.01%
EPS Next 2Y0.9%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-1.19%
Revenue Next 2Y0.55%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
COVH.PA Yearly Revenue VS EstimatesCOVH.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 50M 100M 150M 200M 250M
COVH.PA Yearly EPS VS EstimatesCOVH.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2023 2024 2025 2026 0.5 1 1.5

3

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 17.19 indicates a rather expensive valuation of COVH.
COVH's Price/Earnings is on the same level as the industry average.
COVH is valuated rather cheaply when we compare the Price/Earnings ratio to 27.03, which is the current average of the S&P500 Index.
A Price/Forward Earnings ratio of 13.86 indicates a correct valuation of COVH.
66.67% of the companies in the same industry are cheaper than COVH, based on the Price/Forward Earnings ratio.
COVH's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 36.28.
Industry RankSector Rank
PE 17.19
Fwd PE 13.86
COVH.PA Price Earnings VS Forward Price EarningsCOVH.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of COVH is on the same level as its industry peers.
Based on the Price/Free Cash Flow ratio, COVH is valued a bit more expensive than 64.29% of the companies in the same industry.
Industry RankSector Rank
P/FCF 17.74
EV/EBITDA 18.76
COVH.PA Per share dataCOVH.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates COVH does not grow enough to justify the current Price/Earnings ratio.
The decent profitability rating of COVH may justify a higher PE ratio.
PEG (NY)5.71
PEG (5Y)N/A
EPS Next 2Y0.9%
EPS Next 3YN/A

4

5. Dividend

5.1 Amount

COVH has a Yearly Dividend Yield of 6.25%, which is a nice return.
COVH's Dividend Yield is a higher than the industry average which is at 5.44.
COVH's Dividend Yield is rather good when compared to the S&P500 average which is at 2.40.
Industry RankSector Rank
Dividend Yield 6.25%

5.2 History

The dividend of COVH decreases each year by -3.01%.
Dividend Growth(5Y)-3.01%
Div Incr Years4
Div Non Decr Years4
COVH.PA Yearly Dividends per shareCOVH.PA Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 2024 2025 1 2 3

5.3 Sustainability

85.75% of the earnings are spent on dividend by COVH. This is not a sustainable payout ratio.
DP85.75%
EPS Next 2Y0.9%
EPS Next 3YN/A
COVH.PA Yearly Income VS Free CF VS DividendCOVH.PA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M 400M
COVH.PA Dividend Payout.COVH.PA Dividend Payout, showing the Payout Ratio.COVH.PA Dividend Payout.PayoutRetained Earnings

COVIVIO HOTELS SACA

EPA:COVH (8/6/2025, 5:29:38 PM)

23.9

+0.1 (+0.42%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryDiversified REITs
Earnings (Last)07-16 2025-07-16
Earnings (Next)10-22 2025-10-22
Inst Owners31.29%
Inst Owner ChangeN/A
Ins Owners0%
Ins Owner ChangeN/A
Market Cap3.78B
Analysts82.86
Price Target18.67 (-21.88%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 6.25%
Yearly Dividend1.3
Dividend Growth(5Y)-3.01%
DP85.75%
Div Incr Years4
Div Non Decr Years4
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 17.19
Fwd PE 13.86
P/S 13.57
P/FCF 17.74
P/OCF 10.84
P/B 1.1
P/tB 1.21
EV/EBITDA 18.76
EPS(TTM)1.39
EY5.82%
EPS(NY)1.72
Fwd EY7.21%
FCF(TTM)1.35
FCFY5.64%
OCF(TTM)2.2
OCFY9.22%
SpS1.76
BVpS21.74
TBVpS19.68
PEG (NY)5.71
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 3.14%
ROE 6.54%
ROCE 4.5%
ROIC 3.98%
ROICexc 4.22%
ROICexgc 4.46%
OM 103.45%
PM (TTM) 80.73%
GM 13.66%
FCFM 76.53%
ROA(3y)3.26%
ROA(5y)1.11%
ROE(3y)6.53%
ROE(5y)1.93%
ROIC(3y)3.85%
ROIC(5y)2.91%
ROICexc(3y)4.03%
ROICexc(5y)3.03%
ROICexgc(3y)4.17%
ROICexgc(5y)3.12%
ROCE(3y)4.35%
ROCE(5y)3.29%
ROICexcg growth 3Y33.75%
ROICexcg growth 5Y5.13%
ROICexc growth 3Y32.01%
ROICexc growth 5Y4.39%
OM growth 3Y10.91%
OM growth 5Y0%
PM growth 3Y43.44%
PM growth 5Y-10.66%
GM growth 3Y-31.67%
GM growth 5Y-15.65%
F-Score6
Asset Turnover0.04
Health
Industry RankSector Rank
Debt/Equity 0.74
Debt/FCF 14.45
Debt/EBITDA 7.34
Cap/Depr 235.3%
Cap/Sales 48.63%
Interest Coverage 4.58
Cash Conversion 100.84%
Profit Quality 94.79%
Current Ratio 1.06
Quick Ratio 1.06
Altman-Z 1.05
F-Score6
WACC5.28%
ROIC/WACC0.75
Cap/Depr(3y)165.18%
Cap/Depr(5y)147.82%
Cap/Sales(3y)30.61%
Cap/Sales(5y)33.22%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)245.77%
EPS 3Y62.03%
EPS 5Y-12.16%
EPS Q2Q%-13.75%
EPS Next Y3.01%
EPS Next 2Y0.9%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-4.97%
Revenue growth 3Y14.81%
Revenue growth 5Y2.29%
Sales Q2Q%-12.37%
Revenue Next Year-1.19%
Revenue Next 2Y0.55%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-0.2%
EBIT growth 3Y27.34%
EBIT growth 5Y2.29%
EBIT Next Year-17.92%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-25.64%
FCF growth 3Y35.97%
FCF growth 5Y2.55%
OCF growth 1Y7.43%
OCF growth 3Y30.01%
OCF growth 5Y4.76%